0001053369-13-000053.txt : 20131108 0001053369-13-000053.hdr.sgml : 20131108 20131108171308 ACCESSION NUMBER: 0001053369-13-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131106 FILED AS OF DATE: 20131108 DATE AS OF CHANGE: 20131108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223542636 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 FORMER COMPANY: FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19980121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NIGALAYE ASHOK G CENTRAL INDEX KEY: 0001465825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15697 FILM NUMBER: 131205688 MAIL ADDRESS: STREET 1: C/O EPIC PHARMA, LLC STREET 2: 227-15 NORTH CONDUIT AVENUE CITY: LAURELTON STATE: NY ZIP: 11413 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-11-06 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001465825 NIGALAYE ASHOK G C/O EPIC PHARMA, LLC 227-15 NORTH CONDUIT AVENUE LAURELTON NY 11413 1 1 1 0 Chief Scientific Officer Common Stock 2013-11-06 4 S 0 122200 0.1235 D 22139590 I By Epic Investments, LLC Common Stock 12055183 D Ashok G. Nigalaye is an equity owner and executive officer of each of Epic Investments, LLC ("EI") and Epic Pharma, LLC ("EP"), which is a 10% owner of the issuer, and also serves as a director of the issuer. Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI. Ashok Nigalaye 2013-11-08